nach oben

Erschienen in:

01.05.2024 | News item

Dr. Reddy's recalls six lots of sapropterin due to low potency

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

The US FDA has published a company announcement from Dr. Reddy's Laboratories advising of a voluntarily recall of six lots of sapropterin dihydrochloride powder for oral solution because of powder discoloration and low potency. The issue was identified by an accelerated stability test and because of customer complaints. …

Dr. Reddy's Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency Internet Document : 23 Apr 2024. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dr-reddys-issues-voluntary-nationwide-recall-sapropterin-dihydrochloride-powder-oral-solution-100-mg

Titel: Dr. Reddy's recalls six lots of sapropterin due to low potency
Publikationsdatum: 01.05.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-57897-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Dr. Reddy's recalls six lots of sapropterin due to low potency

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Carboplatin/cisplatin/ifosfamide

Epinephrine/Lidocaine/Nitric-oxide

Cotrimoxazole

Antipsychotics/sodium valproate

Bupropion overdose

Multiple drugs